Boosting mRNA Potential for Therapeutics, Gene-Editing & Vaccine Applications With Scalable Design, Guided Delivery, & Validated Clinical Safety for Patients
With proof-of-concept after the COVID-19 pandemic, the mRNA space stood on firmer ground and was making headlines that proved its value across new diseases. From MHRA’s latest guidance on mRNA personalized cancer vaccines to the world’s first RNA-based CRISPR therapy for Baby KJ, doors were opening to revolutionary therapeutics and gene editing applications.
The 5th mRNA-Based Therapeutics Summit Europe is the ultimate biopharma platform diving into novel mRNA, sa-RNA and circular RNA design to delivery innovations, giving the latest insights and connections to turn these breakthroughs into action. Enhanced with the brand-new Gene Editing Focus Day to harness mRNA's power through transient editing strategies, and Investor-Led sessions on what makes an mRNA platform fundable in 2026, attendees left the meeting with tried and tested strategies to de-risk your programs and secure partnerships in today’s competitive landscape.
100+ senior leaders joined from Moderna, AstraZeneca, CybernaX Bio, Avocet Bio, and others working on R&D, CMC, business development, and regulatory affairs for three days of learning, networking, and collaboration to put you at the forefront of mRNA and gene editing innovation in 2026.
Thank you to our speakers, sponsors, and delegates who joined us in Berlin for the summit! If you are interested in the 2027 event, please get in touch at info@hansonwade.com
2026 Attendees
Explore the 2026 Event Guide
- Reshape gene editing strategies with mRNA and explore its role in safer, transient editing, and novel delivery approaches
- Win the race for the next big mRNA breakthrough with end-to-end insights to take you from early discovery to late-stage manufacturing
- Discover how to best secure funding for your company in 2026 with firsthand insights from experienced investors in mRNA drug pipeline expansion
2026 Partners
Data from later clinical development stage/clinical data was presented. This was interesting.
Senior Vice President, BioNTech
This was an excellent conference, by far one of the best mRNA conferences I have attended. Excellent meeting to meet the leaders in the field. The scientific program, the exchange and the networking were excellent.
Chief Executive Officer, DivinCell
The diversity of topics and attendees was good (suppliers, drug developers, CDMOs, regulatory specialists)
Director, Merck KGaA
Explore the Agenda
Dive into cutting-edge mRNA-based therapeutics with insights from leading biopharma, biotech, and academic experts.
Partner With Us
Showcase your technologies and services to senior decision-makers driving next-generation mRNA innovation.
Join Biopharma Experts
Be part of the only European meeting uniting pre-clinical, clinical, manufacturing, regulatory, and investor experts in the mRNA space.